The World Drug Safety Congress Americas brings together over 1000 top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety.
This year’s agenda will explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating a PV strategy for advanced therapies, and collaborate on medical device safety strategies.
Visit Qinecsa at booth 6 to learn how we’re bringing together best-in-class technology and scientific expertise so we can connect life science companies to the right drug safety solutions.
Attend our CEO, Humaira Qureshi’s presentation ‘Outsourcing Pharmacovigilance Post COVID-19’ on 4 Oct at 11:40 to explore the behavioral shift from pharma companies and regulators following the impact of an unparalleled global public health emergency on traditional pharmacovigilance outsourcing practices, including lessons learned and best practices drawn from our experiences.
Get in touch to book a meeting with us at the event and find out how Qinecsa can help you take drug safety solutions to the next level!
